These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23978543)

  • 21. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormones and their influence on chronic kidney disease.
    Valdivielso JM; Jacobs-Cachá C; Soler MJ
    Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):1-9. PubMed ID: 30320621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadal steroids, salt-sensitivity and renal function.
    Pechere-Bertschi A; Burnier M
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):16-21. PubMed ID: 17143066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of progression of renal disease: current hemodynamic concepts.
    Johnston CI; Risvanis J; Naitoh M; Tikkanen I
    J Hypertens Suppl; 1998 Sep; 16(4):S3-7. PubMed ID: 9817185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Raij L
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of testosterone in the pathogenesis, progression, prognosis and comorbidity of men with chronic kidney disease.
    Dousdampanis P; Trigka K; Fourtounas C; Bargman JM
    Ther Apher Dial; 2014 Jun; 18(3):220-30. PubMed ID: 24119223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan.
    Guo LL; Pan Y; Jin HM
    Nephrol Dial Transplant; 2009 Jun; 24(6):1876-83. PubMed ID: 19164322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and strategies for early detection and management of diabetic kidney disease.
    Radbill B; Murphy B; LeRoith D
    Mayo Clin Proc; 2008 Dec; 83(12):1373-81. PubMed ID: 19046557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes, nephropathy, and the renin system.
    Hollenberg NK
    J Hypertens Suppl; 2006 Mar; 24(1):S81-7. PubMed ID: 16601578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetic nephropathy and molecular biology of the renin-angiotensin system in the diabetic kidney].
    Rodríguez Pérez JC; Barrio Castellanos R
    Med Clin (Barc); 1995 Nov; 105(18):708-15. PubMed ID: 8538254
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.
    Talaat KM; el-Sheikh AR
    Am J Nephrol; 2007; 27(5):435-40. PubMed ID: 17622758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reversal of renal fibrosis: lessons from experimental models].
    Dussaule JC; Chatziantoniou C
    Bull Acad Natl Med; 2008 May; 192(5):987-1000; discussion 1000-1. PubMed ID: 19238788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
    Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
    J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex differences and the role of sex steroids in renal injury.
    Metcalfe PD; Meldrum KK
    J Urol; 2006 Jul; 176(1):15-21. PubMed ID: 16753358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
    Ahmed AK; Kamath NS; El Kossi M; El Nahas AM
    Nephrol Dial Transplant; 2010 Dec; 25(12):3977-82. PubMed ID: 19820248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U; Mayer G
    Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of diabetic nephropathy on the function of the hypophyseal-gonadal system in men].
    Chernyshova TE; Sitnikov VA; Martirosov IuK
    Urol Nefrol (Mosk); 1991; (1):54-7. PubMed ID: 1858209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.